Translink Corporate Finance’s partner in Poland, Holon CF, acted as the advisor to one of the nation’s largest diagnosis and treatment of infertility networks, Klinika Bocian, in acquiring 100% of the shares of Lublin-based infertility treatment clinic, Ab ovo.
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announced the acquisition of M Squared Associates (M2), an industry leading clinical, regulatory, and quality consulting firm serving the medical device and diagnostic industry. Specializing in devices, biologics, and combination products for a wide range of therapeutic areas and disease spaces, M2 is a highly regarded partner to global medical technology organizations ranging from emerging start-ups to multinational device manufacturers.
SAGE Veterinary Centers adds additional practice to their community of hospitals through new partnership with Mid-Columbia Pet Emergency Service. The combination expands SAGE’s paw print in central Washington state and provides value to veterinarians. Translink acted as advisor to the buyer.
HegenbergerSpeculum ApS is a supplier of obstetric speculums specifically designed for after-birth repair of vaginal injuries. Approximately 50% of women suffer from this condition and require suturing after giving birth.
Translink Corporate Finance announced the sale of Centaur Healthcare Limited (trading as “Surepharm”), a contract development manufacturing organisation predominantly servicing the pharmaceutical market, to Chiltern Capital, an ambitious and active private equity investor in the UK lower mid-market. Souters Investments and Bluester Capital co-invested alongside Chiltern with debt financing being provided by Thincats. Surepharm provides a wide range of services from pilot plant facilities for formulation development and pre-production trials to outsourced development, manufacturing and packaging of its products for its customers in the UK and overseas. From its fully licensed and high tech facilities, Surepharm specialises in producing solid dose tablets and capsules including controlled drugs, niche medicines and specials for the human and veterinary markets. Chiltern’s investment will support Surepharm to expand the capacity and capabilities of the company to drive faster growth and enhance its formulation and development offerings. Through the provision of funding for capex investment into new dosage forms alongside the development of the sales and marketing functions, Surepharm will develop its capability to provide an end-to-end service for both new and existing customers. At Translink we are aware that the pharmaceuticals and healthcare market is very active and continues to provide exceptional investment opportunities for investors. Our healthcare experience across many countries/continents means we are ideally positioned in all markets to help other healthcare companies and investors accomplish their strategic M&A goals.
Translink UK is an active and very experienced M&A advisor comprising over 20 individuals across four locations. They work extensively on cross border transactions across a number of sectors. A breadth and depth of experience including industrial positions and within private equity underpins a real focus on client outcomes and drives the effective and practical delivery of corporate transactions.
HealthComp’s acquisition of Gilsbar’s TPA Division will support continued enhancements in client offerings and growth.
Unifeye Vision Partners (UVP), a leading network of comprehensive eye care providers, announced the completion of a strategic partnership with Oceanside-based Pendleton Eye Center (“PEC”) in Southern California. This practice represents UVP’s sixth practice partnership in California, and its second partnership in the greater San Diego region.
Translink Corporate Finance advised Roha Arzneimittel GmbH on the sale of subsidiaries to Convivo Group.
Translink Corporate Finance acted as exclusive M&A advisor to Roha Arzneimittel GmbH in this transaction.
Pathways Health and Community Support, LLC, a portfolio company of Atar Capital and one of the largest providers of behavioral and mental health services in the United States, announced its acquisition of Human Resource Training, Inc. (HRT), an Arizona-based company that provides foster care services, social services and training to families and youth in the central and northern regions of Arizona.
Frontier Dental Superholdings LLC (“Frontier” or “FDS”), a leading dental laboratory platform, announced that it has partnered with and made an investment in Burbank Dental Laboratory, LLC, a full-service dental laboratory based in Burbank, CA.
